Teknova (TKNO) - Total Stockholders' Equity

TKNO (teknova.com) - company brandmark

Alpha Teknova, Inc. (TKNO) provides the biopharmaceutical industry with custom buffers and media essential for the development of gene therapies. Transparent administration and professional management enable the company to effectively scale volumes to meet B2B orders. The business is currently scaling the production of fluids for cell therapy to increase profits amid rising demand. The current metric stands at 0.06. This chart illustrates the asset's market value below.

TKNO Teknova Book Capitalization (07/04/2022 - 10/28/2026)

Teknova (TKNO) - metric breakdowns and financial figures

- price and consensus price forecast:
Share Price Teknova Inc|TKNO - Price Target Chart
- market capitalization data:
Market Value Alpha Teknova, Inc.|TKNO - Total Company Value
- book capitalization data:
Accounting Value per Share Teknova|TKNO - Book Capitalization|Market-to-Book Ratio teknova.com|TKNO - Company Total Assets
- debt and liquidity data:
Debt to Equity Ratio Alpha Teknova, Inc.|TKNO - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Alpha Teknova|TKNO - Company Aggregate Debts|Debt to Book Value Alpha Teknova, Inc.
Fundamental valuation:TKNO - Teknova Inc
Mass-produced product of Alpha Teknova Inc

The operational successes of Alpha Teknova, Inc. (TKNO) are reflected in the dynamics of the firm's current book capitalization. This metric is calculated as the difference between all assets and liabilities, determining the net value of resources. Amid restrained pricing power caused by the biotech startup crisis, this metric confirms the business's financial stability. Capital growth signals viability but does not guarantee profitability. Investors should view the balance sheet as a defensive buffer.

Competitor analysis for Alpha Teknova, Inc.

ISRG: Accounting Capitalization|Company Book Value DHR|BDX (bd.com) - Total Stockholders' Equity|Company Book Value STE|Company Net Assets West Pharma|Baxter Corp - Book Capitalization|Total Stockholders' Equity Masimo Inc. (MASI)|STVN - Book Capitalization|Accounting Capitalization teleflex.com TFX|Book Capitalization MMSI (Merit Medical)|NVST - Book Valuation of Business|ICUI (ICU Medical Corp) - Book Capitalization|Sirona Dental Systems (XRAY) - Company Net Assets|LMAT (LeMaitre Vascular, Inc.) - Book Capitalization|Book Capitalization ATRC|Company Book Value STAAR Surgical (STAA)|Company Book Value Chromadex Corp NAGE|Company Net Assets ZimVie Dental|Accounting Value of Company AngioDynamics Inc. ANGO|Book Capitalization CERS (Cerus Corporation)|MGRM: Book Valuation of Business|Company Book Value sharpstechnology.com|INFU (InfuSystem Holdings, Inc.) - Accounting Capitalization|UTMD: Company Book Value|Book Valuation of Business KORU Medical Systems Inc. (KRMD)|Company Net Assets Nyxoah S.A.|Total Net Assets MBOT (microbotmedical.com)|Company Book Value Pro-Dex|ZTEK - Accounting Value of Company|Elutia Corp - Company Net Assets|MLSS: Book Capitalization|NXGL (NEXGEL, Inc.) - Company Book Value|Retractable Technologies, Inc. (RVP) - Company Net Assets|Book Capitalization HBIO (Harvard Bioscience, Inc.)|Total Stockholders' Equity FEMY|Company Book Value MeihuaMed MHUA|Accounting Capitalization predictive-oncology.com POAI|Company Net Assets Callan JMB (CJMB)|atrioncorp.com - Total Net Assets|Company Book Value NURO (NeuroMetrix)